Seán Kyne (Galway West, Fine Gael) | Oireachtas source

I welcome Ms O'Neill and Mr. Buckley to the meeting. I wish Ms O'Neill well as chairperson. What challenges does she face in the role? Are there specific issues, for example, in the corporate plan for 2013 to 2015? With regard to new product development and standards relating to foreign direct investment, where does the authority come on board in this process?

The US FDA was mentioned. Is there or has there ever been a process whereby the NSAI is or was answerable to the US FDA or are individual companies answerable? How does standardisation work?